Active Ingredient: DURLOBACTAM SODIUM; DURLOBACTAM SODIUM; SULBACTAM SODIUM
Proprietary Name: XACDURO (COPACKAGED)
Dosage Form; Route of Administration: POWDER; INTRAVENOUS
Strength: EQ 500MG BASE/VIAL; EQ 500MG BASE/VIAL;EQ 1GM BASE/VIAL
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N216974
Product Number: 001
Approval Date: May 23, 2023
Applicant Holder Full Name: ENTASIS THERAPEUTICS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
